Blood test for Alzheimer's biomarkers may speed treatment start
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
A new grant from the Valhalla Foundation will help Octave Bioscience advance the development of a biomarker blood test for detecting disease progression in people with multiple sclerosis (MS). The […] The post Octave wins grant to develop blood test for measuring MS progression appeared first on Multiple Sclerosis News Today.| Multiple Sclerosis News Today – The Web's Daily Resource for Multiple Scler...
A new University of Florida study aims to determine which of two blood tests can help doctors better track how cervical cancer responds to treatment. Awarded $1.59 million by the Florida Department of Health’s Cancer Innovation Fund and led by Paul Okunieff, MD, professor (shown right), Department of Radiation Oncology, and David Iglesias, MD, chief,…| Radiation Oncology » College of Medicine » University of Florida
New research identifies blood proteins signaling ALS up to ten years early.| Legal Reader
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
Fujirebio asked the FDA to approve its blood test for Alzheimer's disease, which would be the first commercially available test of its kind.| Alzheimer's News Today
Blood levels of two proteins, known as MMP9 and APP, could serve as biomarkers for fragile X syndrome where genetic testing is not possible.| Fragile X News Today
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.| Lupus News Today
